Skip to content
    Carma Fund logo

    Carma Fund

    Munich, GermanyFounded 2022

    Carma Fund is an early-stage venture capital firm investing in life science and healthcare technologies across Europe. The fund, started in June 2022, focuses on the translation of therapeutics, diagnostics, medtech, and digital health assets.

    32% of their portfolio is in Healthcare. Their most common stage is seed (47% of deals). Average disclosed round size is $32.5M (across 3 rounds with reported amounts).

    Find people at Carma Fund on Goldilocks AI

    Portfolio

    16

    Fund Size

    $61M

    Top Stage

    Seed

    Last 12 Mo

    3

    Team

    CL

    Christian Leikert

    Managing Partner

    MR

    Martin Raditsch

    General Partner

    TH

    Thomas Hanke

    Venture Partner

    MM

    Martin Müller

    Venture Capital

    Looking for someone who isn't listed here?

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    19 investments
    CompanyRound
    Allogenetics logoAllogeneticsSep 2026Series A
    Exciva logoExcivaJan 2026Series B
    WWMT AGOct 2025Unknown
    Elkedonia logoElkedoniaJun 2025Seed
    Exciva logoExcivaJan 2025 · $59MSeries B
    AAkribion TherapeuticsJan 2025Seed
    Akribion logoAkribionJan 2025Seed
    AIgnostics logoAIgnosticsOct 2024 · $34MSeries B
    Symphera logoSympheraSep 2024Seed
    Thryve logoThryveSep 2024Series A
    Epignostix logoEpignostixJul 2024Seed
    ACORAI AB logoACORAI ABJan 2024 · $4.5MSeed
    Thryve logoThryveJan 2024Series A
    Allogenetics logoAllogeneticsJan 2024Seed
    inContAlert logoinContAlertSep 2023Pre-Seed
    OO11 BiomedicalJun 2023Seed
    KKUPANDOSep 2022Series A
    AIgnostics logoAIgnosticsSep 2022Series A
    TECregen logoTECregenSeed

    Looking for the people behind these companies?

    Top Co-Investors

    Last updated: 18 November 2026